Literature DB >> 3123106

Modulation of CD4 antigen expression on human gingival Langerhans cells by gamma interferon.

L J Walsh1, A Parry, A Scholes, G J Seymour.   

Abstract

Human gingival organ culture was used to test the hypothesis that gamma interferon (gamma-IFN), which induces HLA-DR and HLA-DQ antigens on Langerhans cells, modulates CD4 antigen expression on these same cells. Before culture, the density of CD4+ cells in the gingival epithelium was 12.7% +/- 3.8% of the density of CD1+ cells. gamma-IFN (200 IU/ml) enhanced CD4 expression such that at 24 h, all CD1+ cells also expressed CD4. Prostaglandin E2, which in isolation had no effect, partially abrogated the stimulatory effect of gamma-IFN on CD4 expression. These results imply that gamma-IFN and prostaglandin E2 are two signals which regulate CD4 expression on gingival Langerhans cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123106      PMCID: PMC1542103     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Modulation of class II (DR and DQ) antigen expression on gingival Langerhans cells in vitro by gamma interferon and prostaglandin E2.

Authors:  L J Walsh; G J Seymour; R N Powell
Journal:  J Oral Pathol       Date:  1986-07

2.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

3.  T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.

Authors:  T J Harrist; J E Muhlbauer; G F Murphy; M C Mihm; A K Bhan
Journal:  J Invest Dermatol       Date:  1983-02       Impact factor: 8.551

4.  Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.

Authors:  G S Wood; N L Warner; R A Warnke
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

5.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Characterization of Langerhans cells by the use of monoclonal antibodies.

Authors:  G F Murphy; A K Bhan; S Sato; T J Harrist; M C Mihm
Journal:  Lab Invest       Date:  1981-11       Impact factor: 5.662

7.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

8.  Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity.

Authors:  L R Braathen; E Thorsby
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens.

Authors:  W E Biddison; P E Rao; M A Talle; G Goldstein; S Shaw
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man.

Authors:  E G Engleman; C J Benike; E Glickman; R L Evans
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

View more
  1 in total

1.  Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures.

Authors:  E Langhoff; E F Terwilliger; H J Bos; K H Kalland; M C Poznansky; O M Bacon; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.